Another AurA inhibitor MLN8237 could inhibit growth of CML cells harboring BCR-ABL-T315I mutation or Ba/F3 cells artificially introduced with T315I mutational BCR-ABL. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.